华润双鹤：控股子公司获得奥卡西平片药品注册证书

Core Viewpoint - China Resources Double Crane Pharmaceutical Co., Ltd. has received a drug registration certificate for Oxcarbazepine tablets from the National Medical Products Administration, indicating a significant development in its product portfolio [1] Company Summary - The company’s subsidiary, Hunan Xiangzhong Pharmaceutical Co., Ltd., is responsible for the receipt of the drug registration certificate [1] - Oxcarbazepine tablets are indicated for the treatment of primary generalized tonic-clonic seizures and partial seizures in adults and children aged 5 years and older [1]